Latigo Biotherapeutics Funding & Investors
Thousand Oaks, CA
Operator of a drug discovery company intended to develop novel, non-opioid therapies for chronic pain. The company utilizes unique, translated insights to provide a differentiated approach to targeting therapeutics across the blood-nerve barrier, enabling patients to get access to a pain management therapy that does not create addiction, dependence or tolerability.
latigobio.comTotal Amount Raised: $300,000,000
Latigo Biotherapeutics Funding Rounds
Series B
$150,000,000
Series B Investors
Blue Owl CapitalKERN CAPITAL PTY.SanofiQatar Investment AuthorityDeep Track CapitalUniversity of Pittsburgh Medical Center (UPMC)Rock Springs CapitalAccess IndustriesCormorant Asset ManagementAlexandria Real Estate EquitiesWestlake Village BioPartners5am VenturesForesite CapitalSeries A
$135,000,000
Series A Investors
5am VenturesForesite CapitalWestlake Village BioPartnersCorner VenturesSeries Unknown
$15,000,000
Series Unknown Investors
Corner Ventures
Funding info provided by Diffbot.